Go Back   Science Forums Biology Forum Molecular Biology Forum Physics Chemistry Forum > Molecular Research Topics Forum > RNA Techniques Forum
Register Search Today's Posts Mark Forums Read

RNA Techniques Forum Post and discuss RNA methods and RNA science related topics. RNA extraction, cDNA synthesis, RNA EMSA, and other RNA protocols.


Morpholinos and DMD: cardiac function data

Morpholinos and DMD: cardiac function data - RNA Techniques Forum

Morpholinos and DMD: cardiac function data - Post and discuss RNA methods and RNA science related topics. RNA extraction, cDNA synthesis, RNA EMSA, and other RNA protocols.


Reply
 
LinkBack Thread Tools Display Modes
  #1  
Old 09-22-2008, 06:47 PM
Jon Moulton's Avatar
Post-Doc
Points: 8,624, Level: 64 Points: 8,624, Level: 64 Points: 8,624, Level: 64
Activity: 50% Activity: 50% Activity: 50%
 
Join Date: May 2007
Location: Corvallis, OR, USA
Posts: 250
Thanks: 3
Thanked 15 Times in 15 Posts
Default Morpholinos and DMD: cardiac function data



Effective rescue of dystrophin improves cardiac function in dystrophin-deficient mice by a modified morpholino oligomer

Wu et al, Qi Long Lu's group and collaborators.

PNAS advance publication, Sept 2008
Open access pdf available

[Only registered users see links. ]

Antisense oligonucleotide-mediated exon skipping is able to correct out-of-frame mutations in Duchenne muscular dystrophy and restore truncated yet functional dystrophins. However, its application is limited by low potency and inefficiency in systemic delivery, especially failure to restore dystrophin in heart. Here, we conjugate a phosphorodiamidate morpholino oligomer with a designed cell-penetrating peptide (PPMO) targeting a mutated dystrophin exon. Systemic delivery of the novel PPMO restores dystrophin to almost normal levels in the cardiac and skeletal muscles in dystrophic mdx mouse. This leads to increase in muscle strength and prevents cardiac pump failure induced by dobutamine stress in vivo. Muscle pathology and function continue to improve during the 12-week course of biweekly treatment, with significant reduction in levels of serum creatine kinase. The high degree of potency of the oligomer in targeting all muscles and the lack of detectable toxicity and immune response support the feasibility of testing the novel oligomer in treating Duchenne muscular dystrophy patients.
__________________
Jon D. Moulton, Ph.D.
Gene Tools, LLC
[Only registered users see links. ]
Reply With Quote
Reply

Tags
cardiac , data , dmd , function , morpholino dmd mdx mouse , morpholinos


Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off
Trackbacks are On
Pingbacks are On
Refbacks are On

Forum Jump


All times are GMT. The time now is 05:42 AM.


Powered by vBulletin® Version 3.8.4
Copyright ©2000 - 2014, Jelsoft Enterprises Ltd.
Copyright 2005 - 2012 Molecular Station | All Rights Reserved
Page generated in 0.11209 seconds with 15 queries